These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 12894524

  • 1. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
    Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM.
    Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
    [Abstract] [Full Text] [Related]

  • 2. Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumour aggressiveness.
    Lincoln DT, Al-Yatama F, Mohammed FM, Al-Banaw AG, Al-Bader M, Burge M, Sinowatz F, Singal PK.
    Anticancer Res; 2010 Mar; 30(3):767-75. PubMed ID: 20392995
    [Abstract] [Full Text] [Related]

  • 3. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
    Soini Y, Kahlos K, Näpänkangas U, Kaarteenaho-Wiik R, Säily M, Koistinen P, Pääakkö P, Holmgren A, Kinnula VL.
    Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
    [Abstract] [Full Text] [Related]

  • 4. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis.
    Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL.
    Arthritis Rheum; 1999 Nov; 42(11):2430-9. PubMed ID: 10555039
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A, Berggren M, Gasdaska JR, Powis G.
    Cancer Res; 1997 Nov 01; 57(21):4965-70. PubMed ID: 9354464
    [Abstract] [Full Text] [Related]

  • 6. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
    Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D.
    Oncogene; 2002 Sep 12; 21(41):6317-27. PubMed ID: 12214272
    [Abstract] [Full Text] [Related]

  • 7. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.
    Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G.
    Anticancer Res; 1996 Sep 12; 16(6B):3459-66. PubMed ID: 9042207
    [Abstract] [Full Text] [Related]

  • 8. Thioredoxin reductase as a novel molecular target for cancer therapy.
    Nguyen P, Awwad RT, Smart DD, Spitz DR, Gius D.
    Cancer Lett; 2006 May 18; 236(2):164-74. PubMed ID: 15955621
    [Abstract] [Full Text] [Related]

  • 9. Induction of thioltransferase and thioredoxin/thioredoxin reductase systems in cultured porcine lenses under oxidative stress.
    Moon S, Fernando MR, Lou MF.
    Invest Ophthalmol Vis Sci; 2005 Oct 18; 46(10):3783-9. PubMed ID: 16186363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF, Di Trapani G.
    Mol Nutr Food Res; 2009 Jan 18; 53(1):87-103. PubMed ID: 18979503
    [Abstract] [Full Text] [Related]

  • 12. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
    Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, Kalvakolanu DV.
    Oncogene; 2001 Jul 12; 20(31):4235-48. PubMed ID: 11464290
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma.
    Turunen N, Karihtala P, Mantyniemi A, Sormunen R, Holmgren A, Kinnula VL, Soini Y.
    APMIS; 2004 Feb 12; 112(2):123-32. PubMed ID: 15056229
    [Abstract] [Full Text] [Related]

  • 15. Thioredoxin induced antioxidant gene expressions in human lens epithelial cells.
    Yegorova S, Yegorov O, Lou MF.
    Exp Eye Res; 2006 Oct 12; 83(4):783-92. PubMed ID: 16712839
    [Abstract] [Full Text] [Related]

  • 16. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
    Holmgren A, Lu J.
    Biochem Biophys Res Commun; 2010 May 21; 396(1):120-4. PubMed ID: 20494123
    [Abstract] [Full Text] [Related]

  • 17. Electro-acupuncture potentiates the disulphide-reducing activities of thioredoxin system by increasing thioredoxin expression in ischemia-reperfused rat brains.
    Siu FK, Lo SC, Leung MC.
    Life Sci; 2005 Jun 10; 77(4):386-99. PubMed ID: 15894008
    [Abstract] [Full Text] [Related]

  • 18. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D.
    Clin Chim Acta; 2006 May 10; 367(1-2):156-61. PubMed ID: 16458876
    [Abstract] [Full Text] [Related]

  • 19. Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell.
    Cha MK, Kim IH.
    Biochem Biophys Res Commun; 1995 Dec 26; 217(3):900-7. PubMed ID: 8554614
    [Abstract] [Full Text] [Related]

  • 20. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
    Söderberg A, Sahaf B, Rosén A.
    Cancer Res; 2000 Apr 15; 60(8):2281-9. PubMed ID: 10786696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.